Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trial
Chloé Laurencin(Université Claude Bernard Lyon 1), Stéphane Thobois(Université Claude Bernard Lyon 1), Marie Vidailhet(Centre National de la Recherche Scientifique), E. Broussolle, Maxime Bonjour(Université Claude Bernard Lyon 1), Caroline Demily(Université Claude Bernard Lyon 1), Mickaël Alexandre Obadia(Fondation Ophtalmologique Adolphe de Rothschild), Carole Langlois‐Jacques(Université Claude Bernard Lyon 1), Hélène Klinger(Hospices Civils de Lyon), Carine Karachi(Assistance Publique – Hôpitaux de Paris), Eduardo Couchonnal(Hospices Civils de Lyon), Elena Moro(Inserm), Téodor Danaila(Hospices Civils de Lyon), David Grabli(Centre National de la Recherche Scientifique), France Woimant(Fondation de Rothschild), Michaëla Pernon(Fondation de Rothschild), Aurélie Portefaix(Hospices Civils de Lyon), Victoire Leclert(Hospices Civils de Lyon), Emmanuel Roze(Centre National de la Recherche Scientifique), Gustavo Polo(Hospices Civils de Lyon), Behrouz Kassaï(Hospices Civils de Lyon), Laurianne Blanchet(Hospices Civils de Lyon), Aurélia Poujois(Fondation Ophtalmologique Adolphe de Rothschild)
Cited by 1
Related Papers
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
|The American Journal of Human Genetics|2016|449
Trial of Deferiprone in Parkinson’s Disease
|New England Journal of Medicine|2022|226
FXTAS
|Neurology|2012|179
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
|Movement Disorders|2022|178
Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3
|Nature Communications|2019|170